Spark Therapeutics doses first Pompe disease patient in study of experimental gene therapy By: Philadelphia Business Journal via Business Journals February 01, 2021 at 11:02 AM EST The company wants to enroll up to 20 patients with the rare, inherited disease for the study. Read More >>